Ensign Peak Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-47,116
| Closed | -$1.13M | – | 1864 |
|
|
2021
Q2 | $1.13M | Hold |
47,116
| – | – | ﹤0.01% | 1399 |
|
|
2021
Q1 | $1.21M | Buy |
47,116
+29,386
| +166% | +$755K | ﹤0.01% | 1350 |
|
|
2020
Q4 | $337K | Buy |
+17,730
| New | +$337K | ﹤0.01% | 1660 |
|
|
2020
Q3 | – | Sell |
-4,253
| Closed | -$51K | – | 1757 |
|
|
2020
Q2 | $51K | Hold |
4,253
| – | – | ﹤0.01% | 1660 |
|
|
2020
Q1 | $33K | Sell |
4,253
-4,253
| -50% | -$33K | ﹤0.01% | 1612 |
|
|
2019
Q4 | $151K | Buy |
+8,506
| New | +$151K | ﹤0.01% | 1631 |
|